IPO - PALISADE BIO, INC.

Form Type: CORRESP

Filing Date: 2024-12-10

Corporate Action: Ipo

Type: New

Accession Number: 000149315224049440

Filing Summary: Ladenburg Thalmann & Co. Inc. has submitted a concurrence in the request made by Palisade Bio, Inc. to accelerate the effective date of its Registration Statement on Form S-1 (Registration No. 333-282883) to December 11, 2024, at 5:30 p.m. Eastern Time. This acceleration is pursued under Rule 461 of the Securities Act, indicating that Palisade Bio, Inc. is moving forward with an initial public offering (IPO). Ladenburg has confirmed its awareness of the obligations involved in this offering.

Document Link: View Document

Form Type: CORRESP

Filing Date: 2024-12-10

Corporate Action: Ipo

Type: New

Accession Number: 000149315224049441

Filing Summary: Palisade Bio, Inc. is requesting the Securities and Exchange Commission to take action on its Registration Statement on Form S-1, which was originally filed on October 30, 2024. The company aims for the registration statement to become effective at 5:30 p.m. Eastern Time on December 11, 2024. The filing is part of the process for an initial public offering (IPO).

Document Link: View Document